•Genomic characterization determines diagnosis, classification, and prognostication of the myeloid malignancies myelodysplastic syndrome (MDS) and AML. •Recognizing genetic lesions as invariable ...
Panelists discuss how current risk stratification systems, particularly the European Leukemia Net 2022 classification for intensive therapy and the 2024 classification for lower intensity treatments, ...
Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030). Background: A change of staging classification has been associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback